Open AccessA double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis-Ekbom disease)
Author(s) -
Kirti Vishwakarma,
Juhi Kalra,
Ravi Gupta,
Mukesh Sharma,
Taruna Sharma
Publication year - 2016
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.194424
Subject(s) - ropinirole , restless legs syndrome , medicine , tolerability , bupropion , randomized controlled trial , randomization , quality of life (healthcare) , physical therapy , adverse effect , anesthesia , pharmacology , dopaminergic , dopamine agonist , dopamine , nursing , pathology , smoking cessation , insomnia
We aimed to compare the efficacy of fixed doses of bupropion and ropinirole and iron alone for the treatment of restless legs syndrome (RLS) and to look for the tolerability of these medications.